|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Loss from operations | |||||
| Other income: | |||||
| Other income, net | |||||
| Gain related to sale of non-financial asset | |||||
| Net loss | |||||
| Income from discontinued operations | |||||
| Dividend attributable to down round feature of warrants | |||||
| Net loss attributable to common stockholders | |||||
| Basic and diluted net loss per share: | |||||
| Basic | |||||
| Diluted | |||||
| Basic net loss per share | |||||
| Diluted net loss per share | |||||
| Shares used in calculation: | |||||
| Basic shares used in calculation | |||||
| Diluted shares used in calculation | |||||
Loading...